Not available outside of the UK & Ireland.
Application
NBI 27914 has been used as acorticotropin-releasing hormone receptor (CRHR1) antagonist:to study its effects on steroidogenic gene expression in GD15 mouse testis to study its effects on amyloid β production to study its effects on neurogenic activity of neural stem cells in the adult hippocampus
Biochem/physiol Actions
NBI 27914 is a CRF1 corticotropin-releasing factor receptor antagonist.
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: